Technical Analysis for RMTI - Rockwell Medical, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 1.46 | -3.64% | -0.06 |
Earnings due: May 13
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 50 DMA | Bearish | 0.00% | |
Stochastic Reached Oversold | Weakness | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Crossed Above 50 DMA | Bullish | -3.64% | |
Pocket Pivot | Bullish Swing Setup | -3.64% | |
Gapped Down | Weakness | -3.64% | |
Fell Below 50 DMA | Bearish | -2.35% | |
Oversold Stochastic | Weakness | -2.35% | |
NR7 | Range Contraction | -4.90% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 17 hours ago |
10 DMA Resistance | about 17 hours ago |
Fell Below 10 DMA | about 17 hours ago |
Down 5% | about 18 hours ago |
Fell Below Previous Day's Low | about 18 hours ago |
Get a Trading Sidekick!
- Earnings date: 05/13/2024
Rockwell Medical, Inc. Description
Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. The company offers products and services for the treatment of end-stage renal disease, chronic kidney disease (CKD), iron deficiency, secondary hyperparathyroidism, and hemodialysis (HD). Its products are used to cleanse patients' blood and replace nutrients lost during the kidney dialysis process. The company manufactures, sells, delivers, and distributes HD concentrates, such as CitraPure citric-acid concentrate, Dri-Sate dry acid, Renal Pure liquid acid concentrate, dry acid concentrate mixing system, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. It also intends to offer Calcitriol, a generic active vitamin D for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company is also developing Soluble Ferric Pyrophosphate, which is in two Phase III clinical trials for iron therapy treatment in CKD-HD patients. Rockwell Medical, Inc. sells its products directly to hemodialysis providers, as well as through independent sales agents and distributors. The company was founded in 1995 and is based in Wixom, Michigan.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Biopharmaceutical Clinical Medicine Acid Phosphates Vitamins Kidney Disease Dialysis Membrane Technology Thyroid Chronic Kidney Disease End Stage Renal Disease Hemodialysis Renal Disease Stage Renal Disease Organ Failure Renal Dialysis Cleaning Agent Kidney Dialysis Rockwell Medical Fistula Hyperparathyroidism Iron Deficiency Secondary Hyperparathyroidism Treatment Of End Stage Renal Disease
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 6.24 |
52 Week Low | 1.16 |
Average Volume | 228,131 |
200-Day Moving Average | 1.95 |
50-Day Moving Average | 1.51 |
20-Day Moving Average | 1.56 |
10-Day Moving Average | 1.49 |
Average True Range | 0.10 |
RSI (14) | 42.53 |
ADX | 20.91 |
+DI | 16.22 |
-DI | 15.64 |
Chandelier Exit (Long, 3 ATRs) | 1.51 |
Chandelier Exit (Short, 3 ATRs) | 1.72 |
Upper Bollinger Bands | 1.72 |
Lower Bollinger Band | 1.41 |
Percent B (%b) | 0.15 |
BandWidth | 20.14 |
MACD Line | -0.02 |
MACD Signal Line | 0.00 |
MACD Histogram | -0.015 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.61 | ||||
Resistance 3 (R3) | 1.62 | 1.57 | 1.59 | ||
Resistance 2 (R2) | 1.57 | 1.53 | 1.57 | 1.58 | |
Resistance 1 (R1) | 1.51 | 1.51 | 1.49 | 1.51 | 1.57 |
Pivot Point | 1.47 | 1.47 | 1.45 | 1.46 | 1.47 |
Support 1 (S1) | 1.41 | 1.43 | 1.39 | 1.40 | 1.34 |
Support 2 (S2) | 1.36 | 1.40 | 1.36 | 1.33 | |
Support 3 (S3) | 1.30 | 1.36 | 1.33 | ||
Support 4 (S4) | 1.30 |